Premium
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
Author(s) -
Ricceri F.,
Pescitelli L.,
Lazzeri L.,
Di Cesare A.,
Prignano F.
Publication year - 2017
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.14300
Subject(s) - medicine , adalimumab , psoriasis , dermatology , concomitant , dermatologic surgery , cohort , surgery , disease